CHARTWELL RX LLC: $145M Department of Health and Human Services Contract
Summary
The Department of Health and Human Services awarded a $145M delivery order to Chartwell RX LLC for doxycycline hyclate 100 mg oral tablets, a generic antibiotic used in biodefense stockpiles. Because Chartwell RX is a private company, no public ticker is directly mapped, and the contract's impact on publicly traded firms is indirect at best.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $145M contract is a biodefense stockpile purchase, but the recipient is private, so no public ticker is directly exposed.
- 2.No related legislation directly authorizes this specific procurement; the bills are mostly neutral and low-impact.
- 3.Supply chain beneficiaries are speculative and not named, making it difficult to identify public companies that would benefit.
Market Implications
This contract is unlikely to affect public markets. The private recipient means no direct equity exposure. The only potential beneficiaries would be generic drug manufacturers with similar products, but there is no evidence they are involved. The contract size is immaterial to large-cap pharma companies.
⚡ Government Convergence
Active government convergence in this signal’s sector right now.
Over the last 90 days, 45 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 37 federal contracts, 6 procurement notices and 2 bills — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
- ContractMERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract · 2026-09-10
- ContractSCITECH SERVICES INC: $18.3M General Services Administration Contract · 2026-09-10
- Procurement noticeRequest for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-09-11
Full Analysis
This contract is a $145M delivery order under the HHS Office of Assistant Secretary for Preparedness and Response, indicating a strategic stockpile of doxycycline, a critical medical countermeasure against anthrax and other biothreats. The recipient, Chartwell RX LLC, is a private pharmaceutical manufacturer, so there is no direct public equity exposure. The contract runs from June 2025 to June 2027, suggesting a two-year supply agreement.
Because the recipient is private, the contract does not flow to a public parent company. The primary public beneficiaries would be generic drug manufacturers and active pharmaceutical ingredient (API) suppliers, but none are named in the award. Companies like Teva ($TEVA), Hikma ($HIK), or Lupin ($LUPIN) could potentially supply similar products, but there is no evidence they are involved in this specific award. The contract is too small to move these large-cap pharma companies' revenues materially.
The contract aligns with the broader biodefense spending trend, but the related bills in the HillSignal database are mostly neutral and low-impact (1/10), with no direct authorization for this specific procurement. The most relevant bill, HR10405, focuses on pediatric cancer, not antibiotics. Thus, legislative tailwinds are weak.
Historically, biodefense contracts for generic drugs are routine and do not create outsized stock moves unless the recipient is a pure-play public company. Since Chartwell RX is private, the market impact is muted. Supply chain beneficiaries would be API manufacturers like Cambrex ($CBM, private) or Lonza ($LONN.SW), but these are not directly tied to this award.
In summary, this is a moderate-value contract in a niche healthcare segment, but with no public company directly benefiting, the investment implications are minimal. Retail investors should not expect this to drive any specific stock.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $11.3B Department of Health and Human Services Grant
STATE OF RHODE ISLAND DEPARTMENT OF ADMINISTRATION: $2.8B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CALIFORNIA: $1.5B Department of Health and Human Services Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.7B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.6B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Contract Details
Recipient
CHARTWELL RX LLC
Award Amount
$144,579,702
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DELIVERY ORDER
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →